American Heart Journal

Journal

Publication Venue For

  • Association of 25-hydroxyvitamin D with incident coronary heart disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.  217:140-147. 2019
  • C-reactive protein and stroke risk in blacks and whites: The REasons for Geographic And Racial Differences in Stroke cohort.  217:94-100. 2019
  • Cardiogenic shock during heart failure hospitalizations: Age-, sex-, and race-stratified trends in incidence and outcomes.  213:18-29. 2019
  • Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers.  212:1-12. 2019
  • Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).  212:23-35. 2019
  • Fine particulate matter and incident coronary heart disease in the REGARDS cohort.  197:94-102. 2018
  • National patterns in intensity and frequency of outpatient care for apparent treatment-resistant hypertension.  186:29-39. 2017
  • Chocolate intake and incidence of heart failure: Findings from the Cohort of Swedish Men.  183:18-23. 2017
  • Socioeconomic and partner status in chronic heart failure: Relationship to exercise capacity, quality of life, and clinical outcomes.  183:54-61. 2017
  • Diabetes, diabetes severity, and coronary heart disease risk equivalence: REasons for Geographic and Racial Differences in Stroke (REGARDS).  181:43-51. 2016
  • Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: The Look AHEAD randomized trial.  170:770-777.e5. 2015
  • A randomized trial of continuous versus interrupted chest compressions in out-of-hospital cardiac arrest: Rationale for and design of the Resuscitation Outcomes Consortium Continuous Chest Compressions Trial.  169:334-341.e5. 2015
  • Trends in mortality and recurrent coronary heart disease events after an acute myocardial infarction among Medicare beneficiaries, 2001-2009.  170:249-255.e2. 2015
  • Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial.  168:682-689.e1. 2014
  • Physical activity and resting pulse rate in older adults: Findings from a randomized controlled trial.  168:597-604. 2014
  • Proceedings from Duke resistant hypertension think tank.  167. 2014
  • Resuscitation outcomes consortium-amiodarone, lidocaine or placebo study (ROC-ALPS): Rationale and methodology behind an out-of-hospital cardiac arrest antiarrhythmic drug trial.  167. 2014
  • Erratum: Vitamin D levels do not predict cardiovascular events in statin-treated patients with stable coronary disease (American Heart Journal (2012) 164 (387-393)).  166:197. 2013
  • Race, exercise training, and outcomes in chronic heart failure: Findings from Heart Failure - A Controlled Trial Investigating Outcomes in Exercise TraiNing (HF-ACTION).  166. 2013
  • Risk for recurrent coronary heart disease and all-cause mortality among individuals with chronic kidney disease compared with diabetes mellitus, metabolic syndrome, and cigarette smokers.  166. 2013
  • Vitamin D levels do not predict cardiovascular events in statin-treated patients with stable coronary disease.  164:387-393. 2012
  • Differences in symptom presentation and hospital mortality according to type of acute myocardial infarction.  163:572-579. 2012
  • Porcine bioprosthetic heart valves: The next generation.  164:177-185. 2012
  • Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease.  164. 2012
  • Benefit of exercise therapy for systolic heart failure in relation to disease severity and etiology-findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training study.  162:1003-1010. 2011
  • Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both.  162:685-691. 2011
  • The prognostic value of the heart rate response to adenosine in relation to diabetes mellitus and chronic kidney disease.  162:356-362. 2011
  • Relationship of technetium-99m tetrofosmin-gated rest single-photon emission computed tomography myocardial perfusion imaging to death and hospitalization in heart failure patients: Results from the nuclear ancillary study of the HF-ACTION trial.  161:1038-1045. 2011
  • Projected impact of polypill use among US adults: Medication use, cardiovascular risk reduction, and side effects.  161:719-725. 2011
  • Safety and accuracy of a wireless pulmonary artery pressure monitoring system in patients with heart failure.  161:558-566. 2011
  • A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure.  161. 2011
  • Body mass index and health status in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial (BARI 2D).  162. 2011
  • Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease.  160:785-794. 2010
  • Variations in prevalent cardiovascular disease and future risk by metabolic syndrome classification in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.  159:385-391. 2010
  • The effect of obesity on quality of life in patients with diabetes and coronary artery disease.  159:292-300. 2010
  • A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: Results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).  159:987.e1-987.e7. 2010
  • Baseline differences in the HF-ACTION trial by sex.  158. 2009
  • Coffee consumption and risk of heart failure in men: An analysis from the Cohort of Swedish Men.  158:667-672. 2009
  • Myocardial perfusion, function, and dyssynchrony in patients with heart failure: Baseline results from the single-photon emission computed tomography imaging ancillary study of the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) Trial.  158. 2009
  • Distribution and determinants of Doppler-derived diastolic flow indices in African Americans: The Jackson Heart Study (JHS).  158:209-216. 2009
  • Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus.  157:771-776. 2009
  • The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia. A Report From the Women's Ischemia Syndrome Evaluation (WISE).  157:548-555. 2009
  • Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: The Losartan Intervention For End point reduction in hypertension (LIFE) study.  157:177-184. 2009
  • Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006.  156:1026-1034. 2008
  • Trends in quality of care for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006.  156:1045-1055. 2008
  • Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006.  156:1035-1044. 2008
  • An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration.  156:106-111. 2008
  • A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: Rationale, design, and baseline patient characteristics.  156. 2008
  • Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction.  154:1052-1058. 2007
  • Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease.  154:1043-1051. 2007
  • Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease.  154:1035-1042. 2007
  • Effect of exercise training on ventricular function, dyssynchrony, resting myocardial perfusion, and clinical outcomes in patients with heart failure: A nuclear ancillary study of Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION); design and rationale.  154:46-53. 2007
  • Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: A multicenter clinical outcomes trial using nesiritide for TMAC.  153:932-940. 2007
  • Secondary prevention outcomes among black and white cardiac rehabilitation patients.  153:980-986. 2007
  • Atrial septostomy improves survival in select patients with pulmonary hypertension.  153:779-784. 2007
  • Trends in postoperative length of stay after bypass surgery.  152:1194-1200. 2006
  • Outcomes in ambulatory chronic systolic and diastolic heart failure: A propensity score analysis.  152:956-966. 2006
  • Temporal trends and drug exposures in pulmonary hypertension: An American experience.  152:521-526. 2006
  • Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study.  152:126-135. 2006
  • Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function.  151:444-450. 2006
  • Intrafamilial variability of noncompaction of the ventricular myocardium.  151:1012.e7-1012.e14. 2006
  • Self-rated health among women with coronary disease: Depression is as important as recent cardiovascular events.  152:921.e1-921.e7. 2006
  • Outcomes in patients with chronic kidney disease undergoing cardiac rehabilitation.  150:1140-1146. 2005
  • Cocaine and coronary calcification in young adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.  150:921-926. 2005
  • Women in cardiac rehabilitation: Outcomes and identifying risk for dropout.  150:1052-1058. 2005
  • Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery disease.  150:109-115. 2005
  • Tezosentan in patients with acute heart failure: Design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS).  150:46-53. 2005
  • Depression and heart failure in patients with a new myocardial infarction.  149:851-855. 2005
  • A propensity score analysis of the impact of angiotensin-converting enzyme inhibitors on long-term survival of older adults with heart failure and perceived contraindications.  149:737-743. 2005
  • Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris.  149:e1. 2005
  • Remnant-like lipoproteins, hormone therapy, and angiographic and clinical outcomes: The Women's Angiographic Vitamin & Estrogen Trial.  148:293-299. 2004
  • Relation of age and race with hospital death after acute myocardial infarction.  148:92-98. 2004
  • Validation of the accuracy of pretest and exercise test scores in women with a low prevalence of coronary disease: The NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.  147:1085-1092. 2004
  • Metabolic syndrome and coronary angiographic disease progression: The Women's Angiographic Vitamin & Estrogen trial.  146:439-445. 2003
  • The 6-minute walk test: How important is the learning effect?.  146:129-133. 2003
  • Association of consultation between generalists and cardiologists with quality and outcomes of heart failure care.  145:1086-1093. 2003
  • Association of consultation between generalists and cardiologists with quality and outcomes of heart failure care.  145:1086-1093. 2003
  • Role of single photon emission computed tomography imaging in the evaluation of therapy for angina pectoris.  145:952-961. 2003
  • Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS).  146:870-875. 2003
  • Correlates and outcomes of preserved left ventricular systolic function among older adults hospitalized with heart failure.  144:365-372. 2002
  • Large brachial artery diameter is associated with angiographic coronary artery disease in women.  143:802-807. 2002
  • Relationship between activated clotting time during percutaneous intervention and subsequent bleeding complications.  144:501-507. 2002
  • Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: Results from the NHLBI WISE study.  141:735-741. 2001
  • Transesophageal echocardiography in patients with ischemic stroke accurately detects significant coronary artery stenosis and often changes management.  142:916-922. 2001
  • Underutilization of reperfusion therapy in eligible African Americans with acute myocardial infarction: Role of presentation and evaluation characteristics.  142:604-610. 2001
  • Correlates of high HDL cholesterol among women with coronary heart disease..  139:288-296. 2000
  • Biventricular pacing for congestive heart failure: Questions of who, what, where, why, how, and how much.  140:821-823. 2000
  • Correlates of high hdl cholesterol among women with coronary heart disease.  139:288-296. 2000
  • Determinants of outcome in patients with sustained ventricular tachyarrhythmias: The Antiarrhythmics Versus Implantable Defibrillators (AVID) Study Registry.  139:804-813. 2000
  • Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: Results of the elite ventricular function substudy.  139:1081-1087. 2000
  • Rationale and design of the OPTIME CHF trial: Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure.  139:15-22. 2000
  • Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure..  139:15-22. 2000
  • Sensitivity and specificity of transesophageal echocardiography for determination of aortic valve morphology.  139:1071-1076. 2000
  • Trends in severity of hospitalized myocardial infarction: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1994.  139:874-880. 2000
  • Determining prognosis in congestive heart failure: role of the 6-minute walk test..  138:593-596. 1999
  • Economic issues in glycoprotein IIb/IIIa receptor therapy.  138. 1999
  • Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplasty.  138:376-383. 1999
  • Determining prognosis in congestive heart failure: Role of the 6-minute walk test.  138:593-596. 1999
  • Coronary artery disease in diabetic and nondiabetic patients with lower extremity arterial disease: A report from the Coronary Artery Surgery Study Registry..  135:1055-1062. 1998
  • Abciximab therapy in percutaneous intervention: economic issues in the United States..  135:S90-S97. 1998
  • Coronary artery disease in diabetic and nondiabetic patients with lower extremity arterial disease: A report from the coronary artery surgery study registry.  135:1055-1062. 1998
  • Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: A nationwide perspective of current clinical practice.  135:786-796. 1998
  • Hypertension, hypertrophy, hormones, and the heart.  135. 1998
  • Relation of coagulation parameters to patency and recurrent ischemia in the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial.  135:29-37. 1998
  • Atherosclerosis: Risk factors and the vascular endothelium.  131:379-384. 1996
  • Dynamic planar myocardial perfusion imaging in patients with one-vessel disease with intracoronary injection of technetium 99m teboroxime during papaverine-induced coronary hyperemia.  132:1042-1047. 1996
  • Myocardial viability: Methods of assessment and clinical relevance.  132:1226-1235. 1996
  • Predictors of prognosis by quantitative assessment of coronary angiography, single photon emission computed tomography thallium imaging, and treadmill exercise testing.  131:582-590. 1996
  • The placebo effect in cardiovascular disease.  132:1207-1221. 1996
  • Effects of dobutamine on myocardial blood flow, contractile function, and bioenergetic responses distal to coronary stenosis: Implications with regard to dobutamine stress testing.  129:330-342. 1995
  • Implications of increased lung thallium uptake during exercise single photon emission computed tomography imaging.  130:367-373. 1995
  • Relation between diastolic left ventricular function and myocardial blood volume during adenosine-induced coronary hyperemia.  129:696-702. 1995
  • Reply.  129:1223-1224. 1995
  • Results of adenosine single photon emission computed tomography thallium-201 imaging in hemodynamic nonresponders.  130:67-70. 1995
  • Serial changes in left ventricular function after coronary artery bypass: Implications in viability assessment.  129:20-23. 1995
  • Use of a tantalum-178 generator and a multiwire gamma camera to study the effect of the Mueller maneuver on left ventricular performance: Comparison to hemodynamics and single photon emission computed tomography perfusion patterns.  130:1062-1067. 1995
  • Doppler echocardiographic evaluation of the spectrum of left ventricular diastolic dysfunction in essential hypertension.  127:906-913. 1994
  • Dose-response study of intravenous torsemide in congestive heart failure.  128:352-357. 1994
  • Phenomenon of nitrate tolerance.  128:137-146. 1994
  • Transthoracic and transesophageal echocardiographic diagnosis of severe subaortic obstruction produced by an abscess cavity.  128:1252-1255. 1994
  • Determination of ventricular elastance with echocardiography: A reality?.  126:500-502. 1993
  • Identification of high-risk patients with left main and three-vessel coronary artery disease by adenosine-single photon emission computed tomographic thallium imaging.  125:1130-1135. 1993
  • Identification of high-risk patients with left main and three-vessel coronary artery disease using stepwise discriminant analysis of clinical, exercise, and tomographic thallium data.  125:221-225. 1993
  • Simultaneous assessment of left ventricular perfusion and function with technetium-99m sestamibi after coronary artery bypass grafting.  126:1199-1203. 1993
  • Ventricular tachycardia in patients without structural heart disease.  126:1194-1198. 1993
  • Atrioventricular block during adenosine thallium imaging.  123:1569-1574. 1992
  • Differentiation between primary dilated cardiomyopathy and ischemic cardiomyopathy based on right ventricular performance.  123:768-773. 1992
  • Intraoperative transesophageal echocardiographic diagnosis of left atrial pseudoaneurysm.  123:217-218. 1992
  • Serial documentation of changes in a mitral valve vegetation progressing to abscess rupture and fistula formation by transesophageal echocardiography.  124:241-248. 1992
  • Side effects during adenosine thallium imaging with single-port or double-port infusion protocols.  124:610-613. 1992
  • Single photon emission computed tomographic teboroxime imaging with a preprocessing masking technique.  124:1603-1608. 1992
  • The clinical relevance of myocardial viability in patient management.  124:1327-1331. 1992
  • The treadmill exercise score revisited: Coronary arteriographic and thallium perfusion correlates.  124:1581-1586. 1992
  • Transesophageal echocardiographic demonstration of proximal right coronary artery dissection extending into the aortic root.  123:1055-1056. 1992
  • Aortic and mitral valve perforation: Diagnosis by transesophageal echocardiography and Doppler color flow imaging.  121:214-217. 1991
  • Assessment of puimonary vein stenosis by transesophageal echocardiography.  122:1495-1498. 1991
  • Diagnosis of arteriovenous fistula between common iliac artery and vein by color Doppler flow imaging.  122:592-595. 1991
  • Failure of adjuvant heparin to reduce myocardial ischemia in the early treatment of patients with unstable angina.  122:949-954. 1991
  • Isolated partial anomalous pulmonary venous connection: Echocardiographic diagnosis and a new color doppler method to assess shunt volume.  122:870-873. 1991
  • Mitral valve tear complicating percutaneous valvuloplasty: Diagnosis by transesophageal Doppler color flow mapping.  122:238-241. 1991
  • Myocardial imaging with Tc-99m teboroxime: Technique and initial results.  121:889-894. 1991
  • Should we diagnose early coronary artery disease and how?.  122:1798-1799. 1991
  • Single-photon emission computed tomographic thallium imaging with adenosine, dipyridamole, and exercise.  122:279-284. 1991
  • Transesophageal color Doppler diagnosis of anomalous origin of left circumflex coronary artery.  122:571-573. 1991
  • Transient severe mitral regurgitation during percutaneous transluminal coronary angioplasty.  122:1153-1156. 1991
  • Appraisal of clinical models based on results of stress nuclear imaging in risk stratification.  120:1487-1490. 1990
  • Assessment of myocardial viability.  120:1012-1014. 1990
  • Parental history is an independent risk factor for coronary artery disease: The Framingham Study.  120:963-969. 1990
  • Significance of ventricular tachyarrhythmias complicating cardiac catheterization: A CASS Registry study.  119:494-502. 1990
  • Clinical safety and efficacy of once-daily amlodipine for chronic stable angina pectoris.  118:1127-1128. 1989
  • Constrictive pericarditis after cardiac surgery: Report of three cases and review of the literature.  118:1292-1301. 1989
  • Hemodynamic and electrophysiologic effects of amlodipine, a new long-acting calcium antagonist: Preliminary observations.  118:1104-1105. 1989
  • The duration of ST segment depression as an indicator of the pathophysiology of myocardial ischemia.  118:195-197. 1989
  • Use of oral dipyridamole SPECT thallium-201 imaging in detection of coronary artery disease.  118:1022-1027. 1989
  • Dipyridamole cardiac imaging.  115:432-443. 1988
  • Doppler findings in nonimmune hydrops fetalis and cerebral arteriovenous malformation.  115:1138-1140. 1988
  • Left ventricular diastolic function: Evaluation by radionuclide angiography.  115:924-929. 1988
  • Left ventricular pseudoaneurysm due to penetrating injury of the chest: An echocardiographic diagnosis.  115:1134-1136. 1988
  • New myocardial perfusion imaging agents: Description and applications.  115:1111-1117. 1988
  • The role of nitrates, beta blockers, and calcium antagonists in stable angina pectoris.  116:838-848. 1988
  • Effects of beta blockade on systolic and diastolic left ventricular function at rest and during exercise in patients with chronic stable angina pectoris.  113:791-798. 1987
  • Merits and limitations of quantitative treadmill exercise score.  114:819-826. 1987
  • Morphology of occlusive coronary lesions during acute myocardial infarction: An angiographic and clinical analysis.  113:84-89. 1987
  • Thallium imaging with single photon emission computed tomography.  114:852-865. 1987
  • The role of radionuclide cardiac imaging in coronary artery bypass surgery.  113:163-170. 1987
  • Acute myocardial infarction in a patient with anomalous right coronary artery.  112:1092-1094. 1986
  • Age-related changes in left ventricular diastolic performance.  112:75-78. 1986
  • Amiodarone and N-desethylamiodarone concentrations in plasma, red blood cells, and myocardium after a single oral dose: Relation to hemodynamic effects in surgical patients.  111:280-285. 1986
  • Determinants of the changes in left ventricular end-diastolic volume during upright exercise in patients with coronary artery disease.  112:441-446. 1986
  • Effect of gender on left ventricular function during exercise in patients with coronary artery disease.  111:543-546. 1986
  • Left ventricular pressure/volume relationship in coronary artery disease.  112:375-381. 1986
  • Pacemaker therapy in congestive heart failure: A new concept based on excessive utilization of the Frank-Starling mechanism.  112:867-870. 1986
  • Radionuclide evaluation of cardiac function in obesity.  111:1003-1004. 1986
  • Recovery of left ventricular function in peripartum cardiomyopathy.  112:1097-1099. 1986
  • Resting thallium-201 myocardial perfusion patterns in patients with severe left ventricular dysfunction: Differences between patients with primary cardiomyopathy, chronic coronary artery disease, or acute myocardial infarction.  111:760-767. 1986
  • The assessment of contractile reserve after thrombolytic therapy for acute myocardial infarction.  111:821-825. 1986
  • Ventricular systolic and diastolic impairment during pacing-induced myocardial ischemia in coronary artery disease: Simultaneous hemodynamic, electrocardiographic, and radionuclide angiographic evaluation.  112:382-391. 1986
  • Age-related changes in cardiovascular performance in mitral regurgitation: Analysis of 61 patients.  109:442-447. 1985
  • Effects of cardiac medications on ventricular performance: Emphasis on evaluation with radionuclide angiography.  109:1070-1084. 1985
  • Evaluation of patients with acute myocardial infarction: Which test, for whom and why?.  109:391-394. 1985
  • Forward ejection fraction: A new index of left ventricular function in mitral regurgitation.  110:658-664. 1985
  • Increased injury of hypertrophied myocardium with ischemic arrest: Preservation with hypothermia and cardioplegia.  110:1204-1209. 1985
  • Left ventricular pressure/volume relationship in aortic regurgitation.  110:1026-1032. 1985
  • Radionuclide evaluation of exercise left ventricular performance in patients with coronary artery disease.  110:851-856. 1985
  • Thallium-201 myocardial scintigraphy.  109:113-129. 1985
  • The relation between myocardial ischemia and the ejection fraction response to exercise in patients with normal or abnormal resting left ventricular function.  109:1253-1258. 1985
  • The use of rest and exercise radionuclide ventriculography in risk stratification in patients with suspected coronary artery disease.  110:864-872. 1985
  • Acute severe pulmonic valve regurgitation: Pathophysiology, diagnosis, and treatment.  108:567-573. 1984
  • Cold pressor test during two-dimensional echocardiography: Usefulness in detection of patients with coronary disease.  107:278-285. 1984
  • Comparison of patients with ischemic, myopathic, and rheumatic heart diseases as cardiac transplant recipients.  107:8-12. 1984
  • Correlation between changes in R wave amplitude and left ventricular volume induced by rapid atrial pacing.  107:711-717. 1984
  • Doppler echocardiographic features of mechanical alternans.  107:580-583. 1984
  • Effects of resting ischemia assessed by thallium scintigraphy on QRS scoring system for estimating left ventricular function quantified by radionuclide angiography in acute myocardial infarction patients.  107:1210-1214. 1984
  • Issues in the natural history and treatment of coronary heart disease in black populations: Surgical treatment.  108:688-694. 1984
  • Thallium-201 myocardial scintigraphy and left ventricular function at rest in patients with rest angina pectoris.  108:326-332. 1984
  • Assessment of the myocardial perfusion pattern in patients with multivessel coronary artery disease.  106:1089-1096. 1983
  • Two-dimensional echocardiographic detection of left ventricular wall impaction by mitral prosthesis.  106:1069-1076. 1983
  • Pericardiocentesis induced intrapericardial thrombus: Detection by two-dimensional echocardiography.  104:308-311. 1982
  • Quantitative axial oblique contrast left ventriculography: Validation of the method by demonstrating improved visualization of regional wall motion and mitral valve function with accurate volume determinations.  103:185-194. 1982
  • Two-dimensional echocardiographic detection and diagnostic features of left ventricular papillary fibroelastoma.  103:917-918. 1982
  • Two-dimensional echocardiographic detection of arrhythmogenic right ventricular dysplasia.  103:1066-1067. 1982
  • Two-dimensional echocardiographic detection of circulating right atrial thrombi.  103:435-436. 1982
  • Two-dimensional echocardiographic identification of intracardiac leiomyomatosis.  103:915-917. 1982
  • Unstable angina pectoris: Is it time to change our approach?.  103:154-156. 1982
  • Bayes' theorem in perspective: Toward improved interpretation of the exercise test.  101:116-117. 1981
  • Clinical effects of glucose-insulin-potassium on left ventricular function in acute myocardial infarction: Results from a randomized clinical trial.  102:313-324. 1981
  • Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction.  102:1029-1037. 1981
  • Dissecting aneurysm of the ventricular septum following acute myocardial infarction: Diagnosis by real time two-dimensional echocardiography.  101:671-672. 1981
  • Glucose-insulin-potassium induced alterations in individual plasma free fatty acids in patients with acute myocardial infarction.  102:10-15. 1981
  • Modern approach to myocardial infarction: Determination of prognosis and therapy.  101:75-85. 1981
  • Right ventricular infarction and function.  101:215-218. 1981
  • Two-dimensional echographic identification of tumor hemorrhages in atrial myxomas.  101:237-239. 1981
  • Atrial fibrillatory wave size and etiology of heart disease.  98:274. 1979
  • Complete occlusion of the left main coronary artery.  98:83-86. 1979
  • Systolic flutter of the mitral valve.  96:157-162. 1978
  • Echocardiographic features of combined membranous subaortic stenosis and acquired calcific aortic valvulopathy..  94:249-252. 1977
  • Echocardiographic features of combined membranous subaortic stenosis and acquired calcific aortic valvulopathy.  94:349-352. 1977
  • Pulmonary valve fluttering in subpulmonic ventricular septal defect.  94:3-5. 1977
  • The arrhythmogenic effect of static electricity on the dog heart.  93:496-500. 1977
  • Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion.  92:441-454. 1976
  • Serum lipids and glycoproteins in acute myocardial infarction.  90:582-586. 1975
  • Venospasm during cardiac catheterization.  88:813. 1974
  • Venospasm during cardiac catheterization.  88:811-812. 1974
  • Renal abnormalities discovered by routine postangiography abdominal films.  86:57-60. 1973
  • Blood pressures of !Kung bushmen in Northern Botswana.  84:5-12. 1972
  • Friedreich's ataxia and myocardiopathies.  84:843. 1972
  • Renin in differential diagnosis of hypertension.  82:568-570. 1971
  • Salivary gland hemorrhage as a complication of anticoagulation therapy.  82:282-283. 1971
  • Salivary gland hemorrhage-An unusual complication of Coumadin anticoagulation.  80:675-676. 1970
  • Isolated massive chylopericardium.  75. 1968
  • International Standard Serial Number (issn)

  • 0002-8703
  • Electronic International Standard Serial Number (eissn)

  • 1097-6744